메뉴 건너뛰기




Volumn 31, Issue 10, 2007, Pages 1373-1382

Immature and mature monocyte-derived dendritic cells in myelodysplastic syndromes of subtypes refractory anemia or refractory anemia with ringed sideroblasts display an altered cytokine profile

Author keywords

Antigen presenting cells; Monocyte derived dendritic cells; Myelodysplastic syndromes

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

EID: 34547660310     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.11.007     Document Type: Article
Times cited : (25)

References (36)
  • 1
    • 2442584301 scopus 로고    scopus 로고
    • Myelodysplastic syndromes: from pathogenesis and prognosis to treatment
    • Fenaux P. Myelodysplastic syndromes: from pathogenesis and prognosis to treatment. Semin Hematol 41 (2004) 6-12
    • (2004) Semin Hematol , vol.41 , pp. 6-12
    • Fenaux, P.1
  • 2
    • 0028805708 scopus 로고
    • Polyclonal primitive hematopoietic progenitors can be detected in mobilized peripheral blood from patients with high-risk myelodysplastic syndromes
    • Delforge M., Demuynck H., Vandenberghe P., Verhoef G., Zachee P., van Duppen V., et al. Polyclonal primitive hematopoietic progenitors can be detected in mobilized peripheral blood from patients with high-risk myelodysplastic syndromes. Blood 86 (1995) 3660-3667
    • (1995) Blood , vol.86 , pp. 3660-3667
    • Delforge, M.1    Demuynck, H.2    Vandenberghe, P.3    Verhoef, G.4    Zachee, P.5    van Duppen, V.6
  • 3
    • 0031869587 scopus 로고    scopus 로고
    • Patients with high-risk myelodysplastic syndrome can have polyclonal or clonal haemopoiesis in complete haematological remission
    • Delforge M., Demuynck H., Verhoef G., Vandenberghe P., Zachee P., Maertens J., et al. Patients with high-risk myelodysplastic syndrome can have polyclonal or clonal haemopoiesis in complete haematological remission. Br J Haematol 102 (1998) 486-494
    • (1998) Br J Haematol , vol.102 , pp. 486-494
    • Delforge, M.1    Demuynck, H.2    Verhoef, G.3    Vandenberghe, P.4    Zachee, P.5    Maertens, J.6
  • 5
    • 0024509491 scopus 로고
    • Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin
    • Janssen J.W., Buschle M., Layton M., Drexler H.G., Lyons J., van den Berghe H., et al. Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin. Blood 73 (1989) 248-254
    • (1989) Blood , vol.73 , pp. 248-254
    • Janssen, J.W.1    Buschle, M.2    Layton, M.3    Drexler, H.G.4    Lyons, J.5    van den Berghe, H.6
  • 6
    • 0028869121 scopus 로고
    • Cytogenetic clonality analysis in myelodysplastic syndrome: monosomy 7 can be demonstrated in the myeloid and in the lymphoid lineage
    • van Lom K., Hagemeijer A., Smit E., Hahlen K., Groeneveld K., and Lowenberg B. Cytogenetic clonality analysis in myelodysplastic syndrome: monosomy 7 can be demonstrated in the myeloid and in the lymphoid lineage. Leukemia 9 (1995) 1818-1821
    • (1995) Leukemia , vol.9 , pp. 1818-1821
    • van Lom, K.1    Hagemeijer, A.2    Smit, E.3    Hahlen, K.4    Groeneveld, K.5    Lowenberg, B.6
  • 7
    • 0036659925 scopus 로고    scopus 로고
    • Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8
    • Nilsson L., Astrand-Grundstrom I., Anderson K., Arvidsson I., Hokland P., Bryder D., et al. Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8. Blood 100 (2002) 259-267
    • (2002) Blood , vol.100 , pp. 259-267
    • Nilsson, L.1    Astrand-Grundstrom, I.2    Anderson, K.3    Arvidsson, I.4    Hokland, P.5    Bryder, D.6
  • 8
    • 4444247211 scopus 로고    scopus 로고
    • Circulating myeloid and lymphoid precursor dendritic cells are clonally involved in myelodysplastic syndromes
    • Ma L., Delforge M., van Duppen V., Verhoef G., Emanuel B., Boogaerts M., et al. Circulating myeloid and lymphoid precursor dendritic cells are clonally involved in myelodysplastic syndromes. Leukemia 18 (2004) 1451-1456
    • (2004) Leukemia , vol.18 , pp. 1451-1456
    • Ma, L.1    Delforge, M.2    van Duppen, V.3    Verhoef, G.4    Emanuel, B.5    Boogaerts, M.6
  • 9
    • 0029932589 scopus 로고    scopus 로고
    • Immunological abnormalities in myelodysplastic syndromes
    • Hamblin T.J. Immunological abnormalities in myelodysplastic syndromes. Semin Hematol 33 (1996) 150-162
    • (1996) Semin Hematol , vol.33 , pp. 150-162
    • Hamblin, T.J.1
  • 10
    • 0141923848 scopus 로고    scopus 로고
    • A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome
    • Saunthararajah Y., Nakamura R., Wesley R., Wang Q.J., and Barrett A.J. A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome. Blood 102 (2003) 3025-3027
    • (2003) Blood , vol.102 , pp. 3025-3027
    • Saunthararajah, Y.1    Nakamura, R.2    Wesley, R.3    Wang, Q.J.4    Barrett, A.J.5
  • 11
    • 0036720903 scopus 로고    scopus 로고
    • HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome
    • Saunthararajah Y., Nakamura R., Nam J.M., Robyn J., Loberiza F., Maciejewski J.P., et al. HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome. Blood 100 (2002) 1570-1574
    • (2002) Blood , vol.100 , pp. 1570-1574
    • Saunthararajah, Y.1    Nakamura, R.2    Nam, J.M.3    Robyn, J.4    Loberiza, F.5    Maciejewski, J.P.6
  • 13
    • 7344223859 scopus 로고    scopus 로고
    • Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profiles
    • Molldrem J.J., Jiang Y.Z., Stetler-Stevenson M., Mavroudis D., Hensel N., and Barrett A.J. Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profiles. Br J Haematol 102 (1998) 1314-1322
    • (1998) Br J Haematol , vol.102 , pp. 1314-1322
    • Molldrem, J.J.1    Jiang, Y.Z.2    Stetler-Stevenson, M.3    Mavroudis, D.4    Hensel, N.5    Barrett, A.J.6
  • 14
    • 0037031289 scopus 로고    scopus 로고
    • Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes
    • Molldrem J.J., Leifer E., Bahceci E., Saunthararajah Y., Rivera M., Dunbar C., et al. Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes. Ann Intern Med 137 (2002) 156-163
    • (2002) Ann Intern Med , vol.137 , pp. 156-163
    • Molldrem, J.J.1    Leifer, E.2    Bahceci, E.3    Saunthararajah, Y.4    Rivera, M.5    Dunbar, C.6
  • 15
    • 0037111548 scopus 로고    scopus 로고
    • Loss of T-lymphocyte clonal dominance in patients with myelodysplastic syndrome responsive to immunosuppression
    • Kochenderfer J.N., Kobayashi S., Wieder E.D., Su C., and Molldrem J.J. Loss of T-lymphocyte clonal dominance in patients with myelodysplastic syndrome responsive to immunosuppression. Blood 100 (2002) 3639-3645
    • (2002) Blood , vol.100 , pp. 3639-3645
    • Kochenderfer, J.N.1    Kobayashi, S.2    Wieder, E.D.3    Su, C.4    Molldrem, J.J.5
  • 16
    • 0031888417 scopus 로고    scopus 로고
    • Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow
    • Jonasova A., Neuwirtova R., Cermak J., Vozobulova V., Mocikova K., Siskova M., et al. Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow. Br J Haematol 100 (1998) 304-309
    • (1998) Br J Haematol , vol.100 , pp. 304-309
    • Jonasova, A.1    Neuwirtova, R.2    Cermak, J.3    Vozobulova, V.4    Mocikova, K.5    Siskova, M.6
  • 17
    • 0036463753 scopus 로고    scopus 로고
    • Immunosuppressive treatment of acquired aplastic anemia and immune-mediated bone marrow failure syndromes
    • Young N.S. Immunosuppressive treatment of acquired aplastic anemia and immune-mediated bone marrow failure syndromes. Int J Hematol 75 (2002) 129-140
    • (2002) Int J Hematol , vol.75 , pp. 129-140
    • Young, N.S.1
  • 18
    • 0030912049 scopus 로고    scopus 로고
    • The pathophysiology of acquired aplastic anemia
    • Young N.S., and Maciejewski J. The pathophysiology of acquired aplastic anemia. N Engl J Med 336 (1997) 1365-1372
    • (1997) N Engl J Med , vol.336 , pp. 1365-1372
    • Young, N.S.1    Maciejewski, J.2
  • 19
    • 0033508739 scopus 로고    scopus 로고
    • Current concepts: large granular lymphocyte leukemia
    • Lamy T., and Loughran Jr. T.P. Current concepts: large granular lymphocyte leukemia. Blood Rev 13 (1999) 230-240
    • (1999) Blood Rev , vol.13 , pp. 230-240
    • Lamy, T.1    Loughran Jr., T.P.2
  • 20
    • 0032546352 scopus 로고    scopus 로고
    • Dendritic cells and the control of immunity
    • Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
    • (1998) Nature , vol.392 , pp. 245-252
    • Banchereau, J.1    Steinman, R.M.2
  • 21
    • 0033557170 scopus 로고    scopus 로고
    • Mobilizing dendritic cells for tolerance, priming, and chronic inflammation
    • Sallusto F., and Lanzavecchia A. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J Exp Med 189 (1999) 611-614
    • (1999) J Exp Med , vol.189 , pp. 611-614
    • Sallusto, F.1    Lanzavecchia, A.2
  • 22
    • 10144260007 scopus 로고    scopus 로고
    • CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha
    • Caux C., Vanbervliet B., Massacrier C., Dezutter-Dambuyant C., de Saint-Vis B., Jacquet C., et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Med 184 (1996) 695-706
    • (1996) J Exp Med , vol.184 , pp. 695-706
    • Caux, C.1    Vanbervliet, B.2    Massacrier, C.3    Dezutter-Dambuyant, C.4    de Saint-Vis, B.5    Jacquet, C.6
  • 24
    • 1242306184 scopus 로고    scopus 로고
    • A flow cytometric method for determination of absolute counts of myeloid precursor dendritic cells in peripheral blood
    • Ma L., Scheers W., and Vandenberghe P. A flow cytometric method for determination of absolute counts of myeloid precursor dendritic cells in peripheral blood. J Immunol Meth 285 (2004) 215-221
    • (2004) J Immunol Meth , vol.285 , pp. 215-221
    • Ma, L.1    Scheers, W.2    Vandenberghe, P.3
  • 25
    • 0033389158 scopus 로고    scopus 로고
    • Phenotypic and functional characteristics of monocyte-derived dendritic cells from patients with myelodysplastic syndromes
    • Rigolin G.M., Howard J., Buggins A., Sneddon C., Castoldi G., Hirst W.J., et al. Phenotypic and functional characteristics of monocyte-derived dendritic cells from patients with myelodysplastic syndromes. Br J Haematol 107 (1999) 844-850
    • (1999) Br J Haematol , vol.107 , pp. 844-850
    • Rigolin, G.M.1    Howard, J.2    Buggins, A.3    Sneddon, C.4    Castoldi, G.5    Hirst, W.J.6
  • 26
    • 7044262768 scopus 로고    scopus 로고
    • Defective tumor necrosis factor alpha-induced maturation of monocyte-derived dendritic cells in patients with myelodysplastic syndromes
    • Micheva I., Thanopoulou E., Michalopoulou S., Karakantza M., Kouraklis-Symeonidis A., Mouzaki A., et al. Defective tumor necrosis factor alpha-induced maturation of monocyte-derived dendritic cells in patients with myelodysplastic syndromes. Clin Immunol 113 (2004) 310-317
    • (2004) Clin Immunol , vol.113 , pp. 310-317
    • Micheva, I.1    Thanopoulou, E.2    Michalopoulou, S.3    Karakantza, M.4    Kouraklis-Symeonidis, A.5    Mouzaki, A.6
  • 28
    • 0025977966 scopus 로고
    • Immobilized anti-CD5 together with prolonged activation of protein kinase C induce interleukin 2-dependent T cell growth: evidence for signal transduction through CD5
    • Vandenberghe P., and Ceuppens J.L. Immobilized anti-CD5 together with prolonged activation of protein kinase C induce interleukin 2-dependent T cell growth: evidence for signal transduction through CD5. Eur J Immunol 21 (1991) 251-259
    • (1991) Eur J Immunol , vol.21 , pp. 251-259
    • Vandenberghe, P.1    Ceuppens, J.L.2
  • 31
    • 0035140951 scopus 로고    scopus 로고
    • Effects of co-stimulation by CD58 on human T cell cytokine production: a selective cytokine pattern with induction of high IL-10 production
    • Bullens D.M., Rafiq K., Charitidou L., Peng X., Kasran A., Warmerdam P.A., et al. Effects of co-stimulation by CD58 on human T cell cytokine production: a selective cytokine pattern with induction of high IL-10 production. Int Immunol 13 (2001) 181-191
    • (2001) Int Immunol , vol.13 , pp. 181-191
    • Bullens, D.M.1    Rafiq, K.2    Charitidou, L.3    Peng, X.4    Kasran, A.5    Warmerdam, P.A.6
  • 32
    • 0034305809 scopus 로고    scopus 로고
    • Kinetics of dendritic cell activation: impact on priming of TH1 TH2 and nonpolarized T cells
    • Langenkamp A., Messi M., Lanzavecchia A., and Sallusto F. Kinetics of dendritic cell activation: impact on priming of TH1 TH2 and nonpolarized T cells. Nat Immunol 1 (2000) 311-316
    • (2000) Nat Immunol , vol.1 , pp. 311-316
    • Langenkamp, A.1    Messi, M.2    Lanzavecchia, A.3    Sallusto, F.4
  • 33
    • 17144441932 scopus 로고    scopus 로고
    • Evidence for involvement of tumor necrosis factor-alpha in apoptotic death of bone marrow cells in myelodysplastic syndromes
    • Mundle S.D., Ali A., Cartlidge J.D., Reza S., Alvi S., Showel M.M., et al. Evidence for involvement of tumor necrosis factor-alpha in apoptotic death of bone marrow cells in myelodysplastic syndromes. Am J Hematol 60 (1999) 36-47
    • (1999) Am J Hematol , vol.60 , pp. 36-47
    • Mundle, S.D.1    Ali, A.2    Cartlidge, J.D.3    Reza, S.4    Alvi, S.5    Showel, M.M.6
  • 35
    • 15044363362 scopus 로고    scopus 로고
    • Dendritic cells in MDS and AML-cause, effect or solution to the immune pathogenesis of disease?
    • Panoskaltsis N. Dendritic cells in MDS and AML-cause, effect or solution to the immune pathogenesis of disease?. Leukemia 19 (2005) 354-357
    • (2005) Leukemia , vol.19 , pp. 354-357
    • Panoskaltsis, N.1
  • 36
    • 23944435482 scopus 로고    scopus 로고
    • Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes
    • Kufner S., Fleischer R.P., Kroell T., Schmid C., Zitzelsberger H., Salih H., et al. Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes. Cancer Immunol Immunother (2005)
    • (2005) Cancer Immunol Immunother
    • Kufner, S.1    Fleischer, R.P.2    Kroell, T.3    Schmid, C.4    Zitzelsberger, H.5    Salih, H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.